Taiwan FDA registration 2610711bbae0a7b86d3efbe8880449be

"Immulab" Rapid Antibody Medium LISS Additive(Non-Sterile)

TW: "依免羅" 低離子添加液(未滅菌)

Taiwan·Risk Class 1·MD·IMMULAB PTY LTD·Registered Jun 15, 2020 – Jun 15, 2025Expired

Registration details

Analysis ID: 2610711bbae0a7b86d3efbe8880449be
License Form: Ministry of Health Medical Device Import No. 021636
Customs Code: DHA09402163609

Company information

Manufacturer: IMMULAB PTY LTD
Manufacturer Country: Australia
Authorized Representative: GLORY BIOSCIENCE CO., LTD.

Product details

Intended Use: Limited to the first level identification range of intensive medium (B.9600) for in vitro diagnosis of medical device management methods.
Product Type (Level 1): B Hematology and pathology devices
Product Type (Level 2): B9600 Fortified medium for in vitro diagnostics
Import Information: Imported from abroad

Dates and status

Registration Date: Jun 15, 2020
Expiry Date: Jun 15, 2025

About this record

Access comprehensive regulatory information for "Immulab" Rapid Antibody Medium LISS Additive(Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 2610711bbae0a7b86d3efbe8880449be and manufactured by IMMULAB PTY LTD. The authorized representative in Taiwan is GLORY BIOSCIENCE CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.